Loading assets, please wait...
Loading assets, please wait...
Baroness Susan Greenfield is a neuroscientist, writer and broadcaster who has published over 200 papers in peer-reviewed journals. Susan studied for her undergraduate and doctoral degrees at Oxford University, and then held research fellowships at the College de France in Paris, NYU Medical Center in New York and at Melbourne University. She also has received 32 honorary degrees from universities around the world.
Her honours include:
Susan has written many books on the brain and mind, including the best-selling ‘The Human Brain: A Guided Tour’ (1997), ‘The Private Life of the Brain’ (2000) and ‘A Day in the Life of the Brain: Consciousness from Dawn ‘til Dusk’ (2016).
Baroness Greenfield is available for public speaking engagements for both the public and private sectors: she delivers keynote talks, lectures and after dinner speeches on neuroscience and its applications to wider issues such as leadership, creativity and risk-management.
Amongst the many esteemed organizations with whom Susan has worked on public speaking engagements are:
Susan has spent many years identifying and characterising novel brain mechanisms linked to neurodegenerative diseases such as Alzheimer’s and Parkinson’s. As the population in general lives longer, these diseases that are usually associated with older age will become an ever-greater presence in society.
Her research has seen her recognized as one of the foremost experts in the field, developing her theory of neurodegeneration and becoming the driving force behind the biotech firm that she founded and of which she is the CEO – Neuro-Bio Ltd.
Book Susan to talk on this emotive, timely and relevant topic.
What effect are computer games, social media and the internet in general having on the brains of users around the world? With these technologies still being in their relative infancy, the long-term impacts are not yet evident, but Baroness Greenfield suggests that 21st century living could be the basis for an issue she terms ‘Mind Change’.
Like the impact of climate change on the environment and the furious arguments that it inspires between those who feel we are doomed, those who suggest it is exaggerated and those who are hopeful that science can save us, Susan believes that the effect of modern tech on how future generations will think and feel – mind change – will also engender energetic debate and dispute. How do they alter how we process information, the degree to which we take risks, how we socialise and empathise with others and even how we view our own identity?
Gain an insight on this intriguing topic by booking Susan to speak at your event.
The point where philosophy and neuroscience intersect is fascinating and Susan speaks engagingly on this topic that brings together two of her great passions.
Using her expert research into the human mind, Susan will shed light on one of life’s biggest questions – how do we generate consciousness and an awareness of our own identity?
You will learn about how research into neuronal assemblies is helping us to better understand the link between local events in single cells of the brain with large-scale events in macro brain regions and how that relates to our concept of consciousness.
This is a topic that is thought provoking for everyone, presented in a way that will be understandable to the non-specialist.
A UNESCO Institute for Statistics report shows that less than 30% of the world’s researchers are women. As one of the world’s most vociferous advocates of female scientists and the first female director of the Royal Institution, Susan is all too familiar with the challenges facing women in science.
Baroness Susan Greenfield has reported to government on the most pressing issues facing female scientists, including:
She continues to work tirelessly with a passion to level the playing field and work on innovative ways to increase the numbers of women in science.
To find out more about this topic, including why we find ourselves in this situation and how to resolve the issues at stake, book Susan to talk at your event.
Susan has written extensively as a neuroscientist who explores consciousness, cognition, and human nature amongst many other topics you can find her books below and learn more about her scientific expertise and theories on the human brain.
Stay up-to-date with all news relating to Susan Greenfield here.
Baroness Greenfield interview by Robyn Williams – ABC Radio, Australia
Baroness Greenfield interview by Robyn Williams on her Alzheimer's research.
Baroness Greenfield interview by Robyn Williams – ABC Radio, Australia
International Holocaust Memorial Day
Business in the House of Lords, including the debate marking International Holocaust Memorial Day, from Thursday 19 January.
International Holocaust Memorial Day
EAN Congress 2022: Challenges for women in neurology
The 8th edition of Challenges for women in neurology took place in Vienna during the EAN 2022 Annual Congress. Prof. Elena Moro from France and Dr. Antonella Macerollo from the UK finally welcomed in-person participants to this networking event, which has been a regular feature of EAN Congress since the first meeting in 2015.
EAN Congress 2022: Challenges for women in neurology
"...The networking event was closed by the lecture of Baroness Susan Greenfield, Founder and CEO of Neuro-Bio Ltd, a privately-owned biotech based at Oxford University with a therapeutic focus on neurodegenerative disease. She discussed with the audience her journey within neuroscience as a woman in times when there was a huge gender discrepancy in the field..." Read the full article, here.
8th EAN Congress in Vienna
Susan Greenfield speaks at the Opening Session - EAN 2022 Congress
8th EAN Congress in Vienna
On Saturday 25th June, Susan Greenfield will be speaking at the opening session of the EAN 2022 congress, the biggest meeting in Neurology! Her talk will be “Where Neuroscience meets neurology: blowing, expanding, and losing the mind”.
To watch the EAN 2022 Opening Lecture Teaser, click the link.
To have more information about the congress, click the link.
European Biopharmaceutical Review
Susan Greenfield shares her insights on the challenges of developing Alzheimer’s disease treatments.
European Biopharmaceutical Review
Susan Greenfield, Founder and CEO of Neuro-Bio Ltd, shared her insights on the challenges of developing Alzheimer’s disease treatments, and the fundamental flaw with approaches to date on the “European Biopharmaceutical Review”.
To read the full article, click the following: Neuro-Bio.
This article is taken from European Biopharmaceutical Review July 2022, pages 40-42. © Samedan Ltd
The Financial Review
During her recent trip to Australia, Neuro-Bio’s CEO, Susan Greenfield, interviewed by Julie Hare, Education editor for the Australian “Financial Review”.
The Financial Review
In April, Baroness Professor Greenfield published a research paper that proved a drug developed by her Oxford-based start-up Neuro-Bio effectively countered the brain disease in mice.
“No one else has been able to describe the primary mechanism that causes the brain cells to keep on dying, like a snowball, in an inappropriate attempt to grow again,” Professor Greenfield said. “We have shown that a molecule that can normally promote [cell] growth can, in an inappropriate context, turn toxic, so more cells die.”
To read the full article, click the link.
Head First Conference 2022
Keynote Speaker at the Head First Conference 2022
Title: The Neuroscience of Subjective Experience
Head First Conference 2022
Consciousness is the ultimate miracle, - and enigma. However most people take
this subjective inner state for granted without ever reflecting on what could possibly
be happening in their brain each day of their waking lives. We will explore this
deeply fascinating question from the perspective of neuroscience, using a wide
range of examples from daily life such as waking up, walking the dog, dreaming
and experiencing pain to see how the following considerations are key to every
waking moment of the customer experience: intensity and synergy of the senses,
extent of pre-existing associations, and arousal levels. Although we will not solve
the problem of how the water of objective brain mechanisms transforms into the
wine of subjective consciousness, we shall end up with a much clearer idea of the
combination of factors that drive, shape, and control it.
Neuro-Bio's Press Conference at Royal College of Physicians London, 05/04/2022
Neuro-Bio's Press Conference
Neuro-Bio's Press Conference at Royal College of Physicians London, 05/04/2022
On Tuesday the 5th of April, Neuro-Bio’s CEO, Baroness Susan Greenfield, NED, Professor Paul Herrling and Behaviourist, Stuart Williams, held a Press Conference at the Royal College of Physicians London for the publication of their latest results in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI).
Global Woman Club: Notting Hill Meeting
Susan was invited to join inspiring woman for the launch of Global Woman Club Notting Hill Meeting.
Global Woman Club: Notting Hill Meeting
A monthly celebration of female-founders and entrepreneurs, hosted at the incredible Los Mochis restaurant.
The Global Woman Club is a unique community that helps you to build your confidence, increase your ability to earn money, make friends and create a positive impact in the world. Grow your business through a passionate community of professional women who create, inspire and lead. Global Woman Club will help you to move out of your comfort zone and fulfil your true potential.
Rosalind Franklin Institute Science Seminar Series!
Susan Greenfield Starts the Rosalind Franklin Institute Science Seminar Series!
Rosalind Franklin Institute Science Seminar Series!
Baroness Susan Greenfield very much enjoyed starting off the @rosalindfranklininst Science Seminars.
The RFI hosted a wonderful lunch, followed by Susan talking through Neuro-Bio’s novel approach to Alzheimer’s Disease.
RSA: Inspiring Leaders!
INSPIRING LEADERS: BARONESS SUSAN GREENFIELD
RSA: Inspiring Leaders!
https://thersagroup.com/inspiring-leaders-baroness-susan-greenfield/
Careers in Discovery
Don’t become a scientist for status, don’t do it impress people, don’t do it to get rich. Only do it if the work.
Careers in Discovery
"Don't become a scientist for status, don't do it impress people, don't do it to get rich. Only do it if the work itself is something that you find irresistible, because you'll have to work long hours for little money and no security. You have to have a real passion for it."
Susan was the guest on Careers in Discovery as they explored her journey from classicist to scientist to CEO, the unique challenges still faced by female scientists in academia and Biotech, and why resilience & determination are key qualities to develop.
To listen to the interview, search "Careers in Discovery" on Spotify, iTunes, Apple Podcasts or Google Podcasts, or click here.
Carpe Diem Connections By Yvette Francino
Yvette Francino Interviews Baroness Susan Greenfield - Plasticity and the future of Alzheimer’s.
Carpe Diem Connections By Yvette Francino
Yvette Francino interviewed Baroness Susan Greenfield about Brain Plasticity and the Future of Alzheimer's.
Youtube: https://www.youtube.com/watch?v=p_3SsrTNxD8
Blog Post: https://www.carpediemday.com/baroness...
‘If you never fail, you're not being stretched’
Embracing the art of the possible, with scientist Susan Greenfield
‘If you never fail, you're not being stretched’
Want your little girl to believe that anything is possible? Then take her on a guided tour of the thrillingly multifaceted life of Baroness Susan Greenfield, scientist, broadcaster, author and CEO extraordinaire.
Glamorous, funny, and tirelessly innovative, Greenfield could be described as the Madonna of science. But labels imply limits, whereas she blazes with the energy of someone for whom transcendence is the rule, not the exception. Although frankly, rules don’t interest her.
Few people are better qualified to discuss resilience, the joys of style and how to nourish children’s imagination in the digital age. After years as the BBC’s poster-woman for science, today she leads a pioneering biotech start-up that may lead to cures for Alzheimer’s, cancer and – yes! – wrinkles.
How does she do it? ‘It’s about living life from the inside out.’ And also prancing around to Abba, as often as possible, as well as playing Barbies with her honorary goddaughter, Maria.
Full interview here: Strawberries & Cream
The MindBodyBrain Project with Paul Taylor - Podcast
The MindBodyBrain Project
The MindBodyBrain Project with Paul Taylor - Podcast
Today's episode is an exploration of your brain with a quite incredible person. Baroness Susan greenfield is a professor at Oxford university, an honorary Australian and the CEO of a Biotech company called Neuro Bio. She has published 10 books and been awarded 32 honorary degrees by British & foreign universities.
Her work has aimed to uncover some of the most elusive questions about the brain, such as what is consciousness and what can we do to prevent and treat Alzheimer's disease.
In today's session we delve into both of those topics and also explore neuroplasticity, how to keep your brain healthy, the negative impact of today's hyper-stimulating environment on our brains and especially those of kids.
Neuro-Bio’s paper on “International journal of Biochemistry and Biology”
International journal of Biochemistry and Biology
Neuro-Bio’s paper on “International journal of Biochemistry and Biology”
Neuro-Bio’s paper has been published on “International Journal of Biochemistry and Cell Biology” with the title: WHEN A TROPHIC PROCESS TURNS TOXIC: ALZHEIMER’S DISEASE AS AN ABERRANT RECAPITULATION OF A DEVELOPMENTAL MECHANISM. Garcia-Ratés, Sara; Greenfield, Susan.
Award for Excellence - Global Woman's Summit and Gala Dinner
Susan was a speaker at the Global Woman's Summit in June, with the theme: Empowering Women Locally and Connecting them Globally. She was then presented the Global Woman Award for Excellence.
Award for Excellence - Global Woman's Summit and Gala Dinner
More about the Global Woman's Club:
The Global Woman Awards recognises the achievements of women who represent different backgrounds, nationalities, cultures and ages. Our aim is to empower women locally and connect them globally. Women who are contributing for positive change in the world, women who build communities, and share their talents/skills to help other people, deserve to be recognised globally.
International Women’s Day, 2021
It is the female scientists, technicians and mathematicians who have proved vital to the global efforts.
International Women’s Day, 2021
‘It is the female scientists, technicians and mathematicians who have proved vital to the global efforts to tackle the coronavirus pandemic’
By Baroness Susan Greenfield
Read Baroness Greenfield’s recent interview with The Sun who are celebrating International Women’s Day by hailing heroines who helped Britain beat Covid.
Australian Financial Review
"Baroness Susan Greenfield is busy drumming up funding for her fourth start-up, which aims to identify the ageing disease long before symptoms appear..."
Australian Financial Review
"Baroness Susan Greenfield is busy drumming up funding for her fourth start-up, which aims to identify the ageing disease long before symptoms appear..." Read the full article here: Australian Financial Review
ebrain - Joint Neurosciences Council Podcast
Baroness Susan Greenfield in conversation with ebrain's Adrian Wills!
ebrain - Joint Neurosciences Council Podcast
Listen to the podcast, here.
BBC Radio 4 - The World at 1!
Susan Greenfield addresses the recent "manipulated Alzheimer's data may have misled research for 16 years" on the BBC Radio 4 The World at 1 with Edward Sturton (interview starts at 32:40).
Relight Your Fire Podcast - Advancing Science
There are always scientific challenges being faced in laboratories around the world. In this fascinating episode, Baroness Susan Greenfield CBE (Scientist, Author, Broadcaster and Member of the House of Lords) shares some insights into her fight against neurodegenerative diseases such as Alzheimer's with her company Neuro-Bio.
Relight Your Fire Podcast - Advancing Science
Baroness Greenfield discusses various topics, including: the current state of scientific research into Alzheimer's and dementia - and the role inter-generational families can play in combating it; why she feels privileged to be a member of the House of Lords and raise crucial issues on an important platform; and why she's so passionate about highlighting the perils of too much screen time for children.
You can listen to the Podcast here.
Baroness Greenfield opens Aptamer Group’s new state-of-the-art laboratories
Baroness Susan Greenfield opened the new site and presented on the challenges in scientific discovery
Baroness Greenfield opens Aptamer Group’s new state-of-the-art laboratories
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces that it has opened its new facilities in York Science Park, UK, that will enable it to meet the increasing demand for Optimer technology.
The eminent neuroscience researcher Baroness Susan Greenfield opened the new 18,000 sqft site on November 25th with York Central’s MP Rachel Maskell also present at the event. The visitors received a tour of the new premises, including containment level 1 and 2 laboratories, with a presentation from Baroness Greenfield regarding scientific discovery within growing biotech companies... Continue Reading.
The State of Human Touch: Benefits, Barriers and Solutions
Global NIVEA research reveals: human touch is seen as key to happiness and health. Yet, proven health benefits of physical touch are largely unknown.
“Neuroscientist Susan Greenfield’s latest book “Mind Change” reveals how digital technologies are leaving their mark on our brains. We talked to her about physical touch, neurochemistry, and the mental development of our kids.”
Check out NIVEA Global Report 2020: The State of Human Touch - Benefits, Barriers and Solutions
Neuro-Bio 2022 Publications
Since April 2022 Neuro-Bio has had 4 peer-reviewed articles accepted. We are very proud that Neuro-Bio 2022 publications are all in the TOP 5% of journals as they have Impact Factor equal to or greater than 6.
The Feared vs Loved Debate at The Oxford Union Debate
Baroness Greenfield participated in the highly anticipated Feared vs Loved Debate held at The Oxford Union.
Let's delve into some captivating moments captured during this remarkable event.
Neuro-Bio 2023 Publications
In 2023 Neuro-Bio has had 4 peer-reviewed articles accepted:
Rocha, S., et al., A novel peptide ‘T14’ reflects age and photo-aging in human skin. Aging (Albany NY), 2023. 15(12): p. 5279-5289.
Ranglani, S., et al., A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications. International Journal of Molecular Sciences, 2023. 24(12): p. 9961.
Ranglani S, Hasan S, Mahfooz K, Gordon J, Garcia-Rates S, Greenfield S. Antagonism of a key peptide ‘T14’ driving neurodegeneration: Evaluation of a next generation therapeutic. Biomed Pharmacother. 2023 Nov;167:115498. doi: 10.1016/j.biopha.2023.115498. Epub 2023 Sep 15. PMID: 37713989.
Hasan S, Ahmed M, Garcia-Ratés S, Greenfield S. Antagonising a novel toxin “T14” in Alzheimer’s disease: Comparison of receptor blocker versus antibody effects in vitro. Biomed Pharmacother. 2023 Feb;158:114120. doi: 10.1016/j.biopha.2022.114120. Epub 2022 Dec 14. PMID: 36521245.
Neuro-Bio 2024 Publications
In 2024 Neuro-Bio has currently had 1 peer-reviewed article accepted:
Ranglani, S, Hasan S, Komorowska J, Mayag Medina N, Mahfooz K, Ashton A, Garcia-Rates S, Greenfield S. A Novel Peptide Driving Neurodegeneration Appears Exclusively, linked to the α7 Nicotinic Acetylcholine Receptor, 2024 February.
Company No: 04913644
VAT No: GB685718388
The Australian: UK Alzheimer’s scientist Susan Greenfield raising funds for drug therapy
British Baroness Susan Greenfield is talking to high net worth investors in Australia
about bringing her novel therapy to treat Alzheimer’s Disease to the stage where it
can be trialled on humans.
The baroness is the founder and chief executive of Neuro-Bio and last month had
her paper on a new type of drug, known as NBP14, peer reviewed in the
Alzheimer’s & Dementia TRCI.
“The drug will halt Alzheimer’s, I hope,” she said, adding that her research had
reached a point of accelerated learning. “It’s a bit like a jigsaw puzzle. Once you
complete more of the puzzle then things start getting quicker.”
Read more, here
Business Review: New Hope for Alzheimer's as Baroness Scientist Prepares for Drug Trials
Baroness Greenfield talks about the lack of face-to-face meetings which affect our brains
This website is operated by SG Greenfield Ltd and whose address is Building F5, Culham Science Centre, Abingdon, Oxon, OX14 3DB. We are committed to protecting and preserving the privacy of our visitors when visiting our site or communicating electronically with us.
This policy sets out how we process any personal data we collect from you or that you provide to us through our website. We confirm that we will keep your information secure and that we will comply fully with all applicable UK Data Protection legislation and regulations. Please read the following carefully to understand what happens to personal data that you choose to provide to us, or that we collect from you when you visit this site. By visiting www.susangreenfield.com (our website) you are accepting and consenting to the practices described in this policy.
We may collect, store and use the following kinds of personal information about individuals who visit and use our website:
Information you supply to us. You may supply us with information about you by filling in forms on our website. This includes information you provide when you submit a contact/enquiry form. The information you give us may include your name, address, e-mail address and phone number. Should you wish to unsubscribe from receiving communications from us, please send an email to unsubscribe@susangreenfield.com
Information our website automatically collects about you. With regard to each of your visits to our website we may automatically collect information including the following:
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. For detailed information on the cookies we use and the purposes for which we use them see our Cookie Policy further below.
We use the information in the following ways:
Information you supply to us. We will use this information:
Information we automatically collect about you. We will use this information:
This information is collected anonymously and is not linked to information that identifies you as an individual. We also use Google Analytics to track this information. Find out how Google uses your data at
Google Analytics Data UsageAny information you provide to us will either be emailed directly to us or may be stored on a secure server located in the UK. We use a trusted third-party website and hosting provider (Perfect Web Design) to facilitate the running and management of this website. Perfect Web Design meet high data protection and security standards and are bound by contract to keep any information they process on our behalf confidential. Any data that may be collected through this website that Perfect Web Design process, is kept secure and only processed in the manner we instruct them to. Perfect Web Design cannot access, provide, rectify or delete any data that they store on our behalf without permission.
We do not rent, sell or share personal information about you with other people or non-affiliated companies.
We will use all reasonable efforts to ensure that your personal data is not disclosed to regional/national institutions and authorities, unless required by law or other regulations.
Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our site; any transmission is at your own risk. Once we have received your information, we will use strict procedures and security features to try to prevent unauthorised access.
Our site contains content from third-party websites. This content is typically linked via You Tube, or for example links to documents to download from our server. The Author of the content remains the owner of that content at all times. We make no claim whatsoever of any input, ownership, creation of said content unless stated otherwise. Our website is a digital distribution channel of content, and we are permitted to pass on content by the creators / owners. All Video linked to via YouTube is publicly available. S G Greenfield PPS Ltd are simply as permitted embedding it into our website. Please note and observe that external or third-party content, for example documents and videos have their own copyright protection and are protected by law in their respective durisdictions and countries. We cannot accept any responsibility or liability for the contents of third-party content, e.g. documents, images, media. Please check their policies before you submit any data to any third party or their websites.
Our site may, from time to time, contain links to and from the third-party websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check those policies before you submit any personal data to these websites.
You have the right to ensure that your personal data is being processed lawfully (“Subject Access Right”). Your subject access right can be exercised in accordance with data protection laws and regulations. Any subject access request must be made in writing to info@susangreenfield.com, or at the postal address above. We will provide your personal data to you within the statutory time frames. To enable us to trace any of your personal data that we may be holding, we may need to request further information from you. If you have a complaint about how we have used your information, you have the right to complain to the Information Commissioner’s Office (ICO).
Any changes we may make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail. Please check back frequently to see any updates or changes to our privacy policy.
Questions, comments and requests regarding this privacy policy are welcomed and should be addressed to info@susangreenfield.com
Add SG Greenfield to Home screen?
Tap this icon 
on your device
Thank you for contacting us.
Your email has been sent to our enquiry's team, we endeavour to respond as soon as possible.
Have a fabulous rest of your day!
Thank you for signing up to recieve email updates from S G Greenfield.
Please check your email for a confirmation, and please add us to any SPAM filtering you may have.
Have a fabulous rest of your day!
Oops! Looks like you are already signed up!
If you wish to un-subscribe please click the link in your sign-up confirmation email
Close
Oops! Sorry, there was an error trying to send your message.
Error:
We do apologise, please call us on +44 1235 420084, or try again later, thank you for your interest in S G Greenfield.
CloseSign up to stay up to date with Susan Greenfield
Receive a notification when S G Greenfield posts a new update?
Where not stated otherwise, this website and its content are copyright of S G Greenfield - © SG Greenfield 2024 .
All rights reserved. Please see our privacy policy in respect of third parties content rights.
Any redistribution or reproduction of part or all of the contents that are owned by S G Greenfield PPS Ltd or any other third parties, in any form, is prohibited by law, other than the following:
You may not, except with S G Greenfield PPS Ltd or a third party owners express written permission, distribute or commercially exploit the content owned and copyright of S G Greenfield PPS Ltd, or a third party, on this website, in any form. Nor may you transmit it or store it in any other website or other form of electronic retrieval system without our or the third parties permission.
